Updates on new therapies in development for rare liver diseases
Promising results for three drugs for the treatment of three rare liver diseases were presented today at The International Liver Congress 2018 in Paris, France. Sebelipase alfa, approved for treatment of lysosomal acid lipase ...
Apr 14, 2018